Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evidence generation and reproducibility in cell and gene therapy research: A call to action

Molecular Therapy - Methods & Clinical Development(2021)10.1016/j.omtm.2021.06.012Source: DataRank Database

Evidence generation and reproducibility in cell and gene therapy research: A call to action is a research paper published in Molecular Therapy - Methods & Clinical Development (2021). On theSindex it has a DataRank of 0.934. It has been cited 24 times, with 19 citing works in its 1-hop citation network.

N/A

0.934DataRank · unranked

Scored on demand from live citation data

Open Access24 citations · 19 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (32 grants)OA: goldTopics (14)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 52%Citation Network 48%

Base Score Contribution

0.483

From this paper's citation signal

Citation Network Contribution

0.451

From 14 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 19 citers.

Stain-Free total-protein normalization enhances the reproducibility of Western blot data
Analytical Biochemistry202239 citations20 referencesContributes 0.184
Biocooperative Regenerative Materials by Harnessing Blood‐Clotting and Peptide Self‐Assembly
Advanced Materials202420 citations59 referencesContributes 0.052
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
Stem Cells Translational Medicine2022176 citations104 referencesContributes 0.050
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
Value in Health20247 citations51 referencesContributes 0.041
Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation
Advanced Drug Delivery Reviews202262 citations120 referencesContributes 0.035

Authors (38)

Aris Angelis ORCID,Frederick R. Appelbaum ORCID,Nancy C. Andrews ORCID,Susan E. Bates ORCID,Arlene S. Bierman ORCID

Live enrichment

PubMed:34377737 PMC:PMC8322039

World Health Organization

Grant: R01 HL134664

National Institutes of Health

Grant: R01 CA056821

Parker Institute for Cancer Immunotherapy

Grant: R35CA210087

National Cancer Institute

Grant: P30 CA008748

NCI NIH HHS

Grant: P01 CA013106

NIGMS NIH HHS

Grant: R01 GM042699

NIGMS NIH HHS

Grant: R37 GM042699

National Institutes of Health

Grant: 1R01HL134664-01A1

ENHANCING CARDIOPOIETIC REGENERATION FOR ISCHEMIC CARDIOMYOPATHY

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5R35CA210087-07

Human natural killer cells: Advancing biology and clinical applications

National Institutes of Health

Grant: 5R01CA056821-19

Immunization Against Melanoma Differentiation Antigens

Agency for Healthcare Research and Quality

Eli Lilly and Company

Ludwig Institute for Cancer Research

U.S. Department of Health and Human Services

F. Hoffmann-La Roche

AstraZeneca

Boehringer Ingelheim

Astellas Pharma US

Alnylam Pharmaceuticals

Kyowa Hakko Kirin

Pfizer

Biogen

Merck

Bayer Fund

EMD Serono

Genentech

GlaxoSmithKline

Neos Therapeutics

Roche

Swim Across America

Cancer Research Institute

goldLicense: CC BY NC ND

publisherhttps://doi.org/10.1016/j.omtm.2021.06.012

publisherhttps://api.elsevier.com/content/article/PII:S2329050121001145?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050121001145?httpAccept=text/plain

repositoryhttps://pure.knaw.nl/portal/en/publications/a007ba7e-36c5-40c6-83ba-91f5d5136226

repositoryhttps://pureadmin.qub.ac.uk/ws/files/257751183/Call.pdf

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

/dk/atira/pure/subjectarea/asjc/1300/1313/dk/atira/pure/subjectarea/asjc/1300/1311/dk/atira/pure/subjectarea/asjc/1300/1312QH573-671name=Geneticsname=Molecular BiologyQH426-470Editorialname=Molecular MedicineGeneticsCytology